| Gene symbol | IL1R1 | Synonyms | CD121A, CRMO3, D2S1473, IL-1R-alpha, IL-1RT1, IL1R, IL1RA, P80 | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q11.2-q12.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 1 receptor type 1 | ||||
| GTO ID | GTC2202 |
| Trial ID | NCT04119687 |
| Disease | Osteoarthritis |
| Altered gene | IL-1Ra |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | FX201|humantakinogene hadenovec |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | An Open-Label, Single Ascending Dose Study to Assess the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee |
| Year | 2019 |
| Country | United States |
| Company sponsor | Flexion Therapeutics, Inc. |
| Other ID(s) | FX201-2019-001 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||